000 | 01988 a2200601 4500 | ||
---|---|---|---|
005 | 20250517162802.0 | ||
264 | 0 | _c20180514 | |
008 | 201805s 0 0 eng d | ||
022 | _a1873-4758 | ||
024 | 7 |
_a10.1016/j.drugpo.2017.05.019 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGrebely, Jason | |
245 | 0 | 0 |
_aResearch priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs. _h[electronic resource] |
260 |
_bThe International journal on drug policy _c09 2017 |
||
300 |
_a51-60 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
650 | 0 | 4 | _aDisease Management |
650 | 0 | 4 | _aHealth Services Accessibility |
650 | 0 | 4 |
_aHepatitis C _xcomplications |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aResearch |
650 | 0 | 4 |
_aSubstance Abuse, Intravenous _xcomplications |
700 | 1 | _aBruneau, Julie | |
700 | 1 | _aLazarus, Jeffrey V | |
700 | 1 | _aDalgard, Olav | |
700 | 1 | _aBruggmann, Philip | |
700 | 1 | _aTreloar, Carla | |
700 | 1 | _aHickman, Matthew | |
700 | 1 | _aHellard, Margaret | |
700 | 1 | _aRoberts, Teri | |
700 | 1 | _aCrooks, Levinia | |
700 | 1 | _aMidgard, HÃ¥vard | |
700 | 1 | _aLarney, Sarah | |
700 | 1 | _aDegenhardt, Louisa | |
700 | 1 | _aAlho, Hannu | |
700 | 1 | _aByrne, Jude | |
700 | 1 | _aDillon, John F | |
700 | 1 | _aFeld, Jordan J | |
700 | 1 | _aFoster, Graham | |
700 | 1 | _aGoldberg, David | |
700 | 1 | _aLloyd, Andrew R | |
700 | 1 | _aReimer, Jens | |
700 | 1 | _aRobaeys, Geert | |
700 | 1 | _aTorrens, Marta | |
700 | 1 | _aWright, Nat | |
700 | 1 | _aMaremmani, Icro | |
700 | 1 | _aNorton, Brianna L | |
700 | 1 | _aLitwin, Alain H | |
700 | 1 | _aDore, Gregory J | |
773 | 0 |
_tThe International journal on drug policy _gvol. 47 _gp. 51-60 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.drugpo.2017.05.019 _zAvailable from publisher's website |
999 |
_c27344633 _d27344633 |